<code id='5A71C57ED7'></code><style id='5A71C57ED7'></style>
    • <acronym id='5A71C57ED7'></acronym>
      <center id='5A71C57ED7'><center id='5A71C57ED7'><tfoot id='5A71C57ED7'></tfoot></center><abbr id='5A71C57ED7'><dir id='5A71C57ED7'><tfoot id='5A71C57ED7'></tfoot><noframes id='5A71C57ED7'>

    • <optgroup id='5A71C57ED7'><strike id='5A71C57ED7'><sup id='5A71C57ED7'></sup></strike><code id='5A71C57ED7'></code></optgroup>
        1. <b id='5A71C57ED7'><label id='5A71C57ED7'><select id='5A71C57ED7'><dt id='5A71C57ED7'><span id='5A71C57ED7'></span></dt></select></label></b><u id='5A71C57ED7'></u>
          <i id='5A71C57ED7'><strike id='5A71C57ED7'><tt id='5A71C57ED7'><pre id='5A71C57ED7'></pre></tt></strike></i>

          focus

          focus

          author:knowledge    Page View:445
          Two business miniatures talk to each other on coin stacks that are sandwiched by a syringe and a stethoscope — coverage from STAT
          Adobe

          For all the flak they get, the country’s four biggest pharmacy benefit managers reported a surprisingly tame average profit margin in the first three quarters of 2023: 4.5%, less than a third of their drugmaker peers.

          But don’t take their numbers as gospel, experts warned.

          advertisement

          “It’s really easy to move money around inside the books of a vertically integrated organization,” said Karen Van Nuys, a senior fellow at the USC Schaeffer Center for Health Policy and Economics. “If one segment of your vertically integrated organization is not publishing any financial data, it’s a good place to hide stuff.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          The cancer stories no one wants to hear
          The cancer stories no one wants to hear

          KARL-JOSEFHILDENBRAND/AFP/GettyImagesDuringthe11monthswhenmyhusband,Ahmad,wasdyingofbladdercancer,fe

          read more
          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more

          European officials brace for rough respiratory virus season

          FinnbarrWebster/GettyImagesLONDON—HealthofficialsintheU.K.andEuropearerampinguptheircampaignsurginge